Cisco’s Santo Caivano Joins CMT Research Foundation Board of Directors
CMT Research Foundation (CMTRF), a patient-led, non-profit focused on delivering treatments and cures for Charcot-Marie-Tooth (CMT) disease, today announced that Santo Caivano, Director, Customer Engagements of Cisco’s CAP (Critical Accounts Program) Americas team,...CMT Research Update/Armatus Bio
Armatus Bio has partnered with Andelyn Biosciences, Inc., a cell and gene therapy Contract Development and Manufacturing Organization to accelerate manufacturing of an Armatus gene therapy treatment for Charcot-Marie-Tooth Type 1A. The goal is to maximize program...![An Extraordinary Year and the Road Ahead](https://cmtrf.org/wp-content/uploads/2024/01/An-Extraordinary-Year-and-the-Road-Ahead-2-1080x630.png)
An Extraordinary Year and the Road Ahead
As we begin 2024, I want to take a look back and celebrate the extraordinary year we had at the CMT Research Foundation. Since 2018, CMTRF has had an outsized impact on inspiring drug hunters to work on developing therapeutics for CMT and establishing itself as a key...‘Amazon Smile’ Program Discontinued
On February 20th, 2023, Amazon ended their Amazon Smile Charity Program. Thank you to the nearly 200 people who supported the CMT Research Foundation through this program. In total, the community was able to raise: Interested in finding a new way to make a difference,...![Legacy – an Anthem for Patients with CMT](https://cmtrf.org/wp-content/uploads/2022/05/Dina.jpg)